CMS seeks to enhance Medicare Advantage and Part D programs, including coverage for anti-obesity medications. The Centers for Medicare and Medicaid Services (CMS) recently proposed updates to Medicare…
Read MoreHealth
House Committee Chair Proposes Veteran Healthcare Access Bill
The legislation would require coverage of alternative healthcare if the VA does not schedule appointments within 20 days. House Veterans Affairs Committee chair Representative Mike Bost proposed a…
Read More
Supreme Court Hears Arguments on Flavored E-Cig Regulations
Justices question alleged inconsistencies in the FDA approval process. The Supreme Court heard arguments this week on the regulation of flavored e-cigarettes, reviewing allegations that the Food and…
Read More
Supreme Court Hears Tennessee Transgender Policy Case
Oral arguments address the state’s ban on transgender interventions for those under 18. The Supreme Court heard arguments this week in the case against Tennessee’s law banning transgender…
Read More
Senate Majority Leader Advocates for Telehealth Medicare Funding
He calls telehealth a “lifeline, not a luxury” for elderly and rural communities. Senate Majority Leader Chuck Schumer of New York called for the continuation of Medicare’s telehealth…
Read More
FDA Recalls Umary Hyaluronic Acid Supplements Sold through Amazon
One lot number was found to be contaminated with over-the-counter drugs. The Food and Drug Administration (FDA) recently issued a recall on Umary-branded hyaluronic acid supplements, warning that…
Read More
House Advances Overhaul of Veterans’ Healthcare
The bipartisan bill expands in-home care for veterans and mental health support for caregivers. The House of Representatives passed the Senator Elizabeth Dole 21st Century Veterans Healthcare and…
Read More
CDC Reports Slowest Increase in Syphilis Rate in 20 Years
Total infections rose by 1 percent in 2023 over the prior year. The Centers for Disease Control and Prevention (CDC) released data this month showing a reduction in…
Read More
FDA Moves to Eliminate Oral Phenylephrine from OTC Nasal Decongestants
Review finds oral phenylephrine ineffective, leading to a proposal for market removal. The U.S. Food and Drug Administration (FDA) recently proposed removing oral phenylephrine from over-the-counter (OTC) products…
Read More
FTC Refunds Consumers for Deceptive Alcohol-Craving Supplement Claims
Purchasers of Sobrenix receive compensation after FTC addresses unsubstantiated health claims. The Federal Trade Commission (FTC) is issuing more than $536,000 in refunds to consumers who purchased Sobrenix,…
Read More